Mangalam Drugs And Organics Limited NSE Symbol:MANGALAM, BSE Security Code:532637 has declared its 4th(fourth) quarter audited Standalone financial report from the month of January, 2020 to the month of March, 2020; for the fiscal year 2019-20.
Revenue Reported by Mangalam Drugs And Organics Limited for Fourth Quarter FY, 2019-20 | ||||
Current Quarter (January, 2020 - March, 2020) | Previous Quarter (October, 2019 - December, 2019) | Corresponding Quarter (January, 2019 - March, 2019) | 12 Months Ended (April, 2019 - March, 2020) | Corresponding 12 Months Ended (April, 2018 - March, 2019) |
88.55 | 62.60 | 48.29 | 283.53 | 227.90 |
Calculated Revenue of Mangalam Drugs And Organics Limited for Fourth Quarter FY, 2019-20 | |||||
Current(March, 2020) VS Previous(December, 2019) | Current(March, 2020) VS Corresponding(March, 2019) | 12 months Ended(April, 2019 - March, 2020) VS Corresponding 12 months Ended(April, 2018 - March, 2019) | |||
Change | Change % | Change | Change % | Change | Change % |
25.95 | 41.45%(Revenue Increase) | 40.26 | 83.37%(Revenue Increase) | 55.63 | 24.41%(Revenue Increase) |
Revenue: Mangalam Drugs And Organics Limited's financial report shows that the company's revenue increased by 41.45% in QoQ(Quarter on Quarter) / current quarter(January, 2020 - March, 2020) for revenue increase of Rs.25.95 crores, as the company posted revenue of Rs.88.55 crores; in compare to previous quarter(October, 2019 - December, 2019) when the company reported revenue of Rs.62.60 crores.
The result also shows that the company's revenue increased by 83.37% in YoY(Year over Year) / in current quarter(January, 2020 - March, 2020) for revenue increase of Rs.40.26 crores; in compare to corresponding quarter(January, 2019 - March, 2019) when the company posted revenue of Rs.48.29 crores
The company also reported that its revenue increased by 24.41% in 12 months end(April, 2019 - March, 2020) for revenue increase of Rs.55.63 crores, since the company reported revenue of Rs.283.53 crores; in compare to corresponding 12 months end(April, 2018 - March. 2019) when the company posted revenue of Rs.227.90 crores.
Gross Margin(%) Reported by Mangalam Drugs And Organics Limited for Fourth Quarter FY, 2019-20 | ||||
Current Quarter (January, 2020 - March, 2020) | Previous Quarter (October, 2019 - December, 2019) | Corresponding Quarter (January, 2019 - March, 2019) | 12 Months Ended (April, 2019 - March, 2020) | Corresponding 12 Months Ended (April, 2018 - March, 2019) |
52.38 | 46.14 | 18.51 | 43.05 | 19.11 |
Calculated Gross Margin(%) of Mangalam Drugs And Organics Limited for Fourth Quarter FY, 2019-20 | |||||
Current(March, 2020) VS Previous(December, 2019) | Current(March, 2020) VS Corresponding(March, 2019) | 12 months Ended(April, 2019 - March, 2020) VS Corresponding 12 months Ended(April, 2018 - March, 2019) | |||
Change | Change % | Change | Change % | Change | Change % |
6.23 | 13.51%(GM Increase) | 33.87 | 182.97%(GM Increase) | 23.94 | 125.30%(GM Increase) |
Gross Margin(%)/ GM: The company's financial report indicates, the company's GM increased by 13.51% in QoQ(Quarter on Quarter) / current quarter(January, 2020 - March, 2020) for 6.23% GM increase, as the company reported 52.38% GM; in compare to previous quarter(October, 2019 - December, 2019) when the company reported 46.14% GM.
The result also indicates, the company's GM increased by 182.97% in YoY(Year over Year) / in current quarter(January, 2020 - March, 2020) for 33.87% GM increase; in compare to corresponding quarter(January, 2019 - March, 2019) when the company reported 18.51% GM.
The company also reported that its GM increased by 125.30% in 12 months end(April, 2019 - March, 2020) for 23.94% GM increase, since the company reported 43.05% GM; in compare to corresponding 12 months end(April, 2018 - March. 2019) when the company reported 19.11% GM.
EBITDA Reported by Mangalam Drugs And Organics Limited for Fourth Quarter FY, 2019-20 | ||||
Current Quarter (January, 2020 - March, 2020) | Previous Quarter (October, 2019 - December, 2019) | Corresponding Quarter (January, 2019 - March, 2019) | 12 Months Ended (April, 2019 - March, 2020) | Corresponding 12 Months Ended (April, 2018 - March, 2019) |
7.61 | 5.61 | 0.47 | 24.87 | 10.00 |
Calculated EBITDA of Mangalam Drugs And Organics Limited for Fourth Quarter FY, 2019-20 | |||||
Current(March, 2020) VS Previous(December, 2019) | Current(March, 2020) VS Corresponding(March, 2019) | 12 months Ended(April, 2019 - March, 2020) VS Corresponding 12 months Ended(April, 2018 - March, 2019) | |||
Change | Change % | Change | Change % | Change | Change % |
2.00 | 35.65%(EBITDA Increase) | 7.14 | 1519.15%(EBITDA Increase) | 14.87 | 148.70%(EBITDA Increase) |
EBITDA/ Earnings before interest, tax, depreciation and amortization: The company's financial report shows that the company's EBITDA increased by 35.65% in QoQ(Quarter on Quarter) / current quarter(January, 2020 - March, 2020) for EBITDA increase of Rs.2.00 crores, as the company posted EBITDA of Rs.7.61 crores; in compare to previous quarter(October, 2019 - December, 2019) when the company reported EBITDA of Rs.5.61 crores.
The result also shows that the company's EBITDA increased by 1519.15% in YoY(Year over Year) / in current quarter(January, 2020 - March, 2020) for EBITDA increase of Rs.7.14 crores; in compare to corresponding quarter(January, 2019 - March, 2019) when the company posted EBITDA of Rs.0.47 crore
The company also reported that its EBITDA increased by 148.70% in 12 months end(April, 2019 - March, 2020) for EBITDA increase of Rs.14.87 crores, since the company reported EBITDA of Rs.24.87 crores; in compare to corresponding 12 months end(April, 2018 - March. 2019) when the company posted EBITDA of Rs.10.00 crores.
Profit and Loss Reported by Mangalam Drugs And Organics Limited for Fourth Quarter FY, 2019-20 | ||||
Current Quarter (January, 2020 - March, 2020) | Previous Quarter (October, 2019 - December, 2019) | Corresponding Quarter (January, 2019 - March, 2019) | 12 Months Ended (April, 2019 - March, 2020) | Corresponding 12 Months Ended (April, 2018 - March, 2019) |
5.05(Profit ) | 1.65(Profit ) | 6.01(Loss ) | 8.25(Profit ) | 8.03(Loss ) |
Calculated Profit and Loss of Mangalam Drugs And Organics Limited for Fourth Quarter FY, 2019-20 | |||||
Current(March, 2020) VS Previous(December, 2019) | Current(March, 2020) VS Corresponding(March, 2019) | 12 months Ended(April, 2019 - March, 2020) VS Corresponding 12 months Ended(April, 2018 - March, 2019) | |||
Change | Change % | Change | Change % | Change | Change % |
3.40 | 206.06%(Profit Increase) | 11.06 | 184.03%(Profit Increase) | 16.28 | 202.74%(Profit Increase) |
Profit and Loss / PAT(Profit after Tax): The company's financial report shows that the company's profit increased by 206.06% in QoQ(Quarter on Quarter) / current quarter(January, 2020 - March, 2020) for profit increase of Rs.3.40 crores, as the company posted profit of Rs.5.05 crores; in compare to previous quarter(October, 2019 - December, 2019) when the company reported profit of Rs.1.65 crores.
The result also shows that the company's profit increased by 184.03% in YoY(Year over Year) / in current quarter(January, 2020 - March, 2020) for profit increase of Rs.11.06 crores; in compare to corresponding quarter(January, 2019 - March, 2019) when the company posted loss of Rs.6.01 crores
The company also reported that its profit increased by 202.74% in 12 months end(April, 2019 - March, 2020) for profit increase of Rs.16.28 crores, since the company reported profit of Rs.8.25 crores; in compare to corresponding 12 months end(April, 2018 - March. 2019) when the company posted loss of Rs.8.03 crores.
EPS Reported by Mangalam Drugs And Organics Limited for Fourth Quarter FY, 2019-20 | ||||
Current Quarter (January, 2020 - March, 2020) | Previous Quarter (October, 2019 - December, 2019) | Corresponding Quarter (January, 2019 - March, 2019) | 12 Months Ended (April, 2019 - March, 2020) | Corresponding 12 Months Ended (April, 2018 - March, 2019) |
3.19 | 1.04 | 3.80(Negative) | 5.21 | 5.07(Negative) |
Calculated EPS of Mangalam Drugs And Organics Limited for Fourth Quarter FY, 2019-20 | |||||
Current(March, 2020) VS Previous(December, 2019) | Current(March, 2020) VS Corresponding(March, 2019) | 12 months Ended(April, 2019 - March, 2020) VS Corresponding 12 months Ended(April, 2018 - March, 2019) | |||
Change | Change % | Change | Change % | Change | Change % |
2.15 | 206.73%(EPS Increase) | 6.99 | 183.95%(EPS Increase) | 10.28 | 202.76%(EPS Increase) |
EPS /Earning per Share: The company's financial report shows that the company's EPS increased by 206.73% in QoQ(Quarter on Quarter) / current quarter(January, 2020 - March, 2020) for EPS increase of Rs.2.15, as the company posted EPS of Rs.3.19; in compare to previous quarter(October, 2019 - December, 2019) when the company reported EPS of Rs.1.04.
The result also shows that the company's EPS increased by 183.95% in YoY(Year over Year) / in current quarter(January, 2020 - March, 2020) for EPS increase of Rs.6.99; in compare to corresponding quarter(January, 2019 - March, 2019) when the company posted Negative EPS of Rs.3.80
The company also reported that its EPS increased by 202.76% in 12 months end(April, 2019 - March, 2020) for EPS increase of Rs.10.28, since the company reported EPS of Rs.5.21; in compare to corresponding 12 months end(April, 2018 - March. 2019) when the company posted Negative EPS of Rs.5.07.
Assets Reported by Mangalam Drugs And Organics Limited for Fourth Quarter FY, 2019-20 | ||||
Details | Non-current Assets | Current Assets | ||
Current Quarter(March, 2020) | Previous Year End(March, 2019) | Current Quarter(March, 2020) | Previous Year End(March, 2019) | |
Reported | 111.49 | 106.32 | 119.17 | 105.04 |
Change | Change % | Change | Change % | |
Calculated | 5.17 | 4.86%(Assets Increase) | 14.13 | 13.45%(Assets Increase) |
Assets:The company reported its non-current assets increased by 4.86% in current year end(March, 2020) for non-current assets increase of Rs.5.17 crores, since the company reported net non-current assets of Rs.111.49 crores; in compare to previous year end(March, 2019) when the company reported net non-current assets of Rs.106.32 crores.
The balance sheet of the company also shows that, its current assets increased by 13.45% in current year end(March, 2020) for current assets increase of Rs.14.13 crores, as the company reported net current assets of Rs.119.17 crores; against previous year end(March, 2019) when the company reported net current assets of Rs.105.04 crores.
Liabilities Reported by Mangalam Drugs And Organics Limited for Fourth Quarter FY, 2019-20 | ||||
Details | Non-current Liabilities | Current Liabilities | ||
Current Quarter(March, 2020) | Previous Year End(March, 2019) | Current Quarter(March, 2020) | Previous Year End(March, 2019) | |
Reported | 17.26 | 24.88 | 109.47 | 90.81 |
Change | Change % | Change | Change % | |
Calculated | 7.62 | 30.63%(Liabilities Decrease) | 18.66 | 20.55%(Liabilities Increase) |
Liabilities:The company reported its non-current liabilities decreased by 30.63% in current year end(March, 2020) for non-current liabilities decrease of Rs.7.62 crores, since the company reported net non-current liabilities of Rs.17.26 crores; in compare to previous year end(March, 2019) when the company reported net non-current liabilities of Rs.24.88 crores.
The balance sheet of the company also shows that, its current liabilities increased by 20.55% in current year end(March, 2020) for current liabilities increase of Rs.18.66 crores, as the company reported net current liabilities of Rs.109.47 crores; against previous year end(March, 2019) when the company reported net current liabilities of Rs.90.81 crores.
***All amounts are given in Crore Indian Rupees(INR) except EPS (Earnings per share) which are in Indian Rupees(INR) only.***
Gross Margin=Total Revenue from Operations -(Cost of Materials Consumed + Purchases of stock-in-trade - Changes in inventories of finished goods, work-in-progress and stock-in-trade).
Gross Margin%=(Gross Margin / Total Revenue from Operations)*100.
EBITDA=Commission/Interest + Depreciation and Amortization + Tax + Profit/Loss (PAT).
1 Lac = 100,000.
1 Million = 10 Lacs.
1 Crore = 10 Millions.
1 Crore = 100 Lacs.
1 Billion = 1000 Millions.
1 Billion = 100 Crores.
Comments